MoonLake Immunotherapeutics (MLTX) Sector
Health Care

(Current) $56.20
1.31 (2.39%) Open Price: 55.75

MoonLake Immunotherapeutics is a clinical-stage biopharmaceutical company unlocking the potential of Sonelokimab, the novel investigational Nanobody® for the treatment of inflammation, to revolutionize outcomes for patients

(08/29/25) $55.75
(08/31/25) $54.89
(08/31/25) (Qty.)607,921
(08/29/25) $53.18
(08/29/25) $56.18
(08/10/25) $51.74
(08/24/25) $56.78
Stocktwits
LetsEncrypt SSL Secure Stripe Payment Processing